Skip to content
10-Q

Quarterly Report

CV Sciences, Inc. CVSI

0000950170-25-071559

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 11, 2025 184.26M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $498K
Long Term Debt Q1 2025 · Dec 31, 2024 $0
Short Term Debt Q1 2025 · Mar 31, 2025 $770K
Short Term Debt Q1 2025 · Dec 31, 2024 $677K
Current Liabilities Q1 2025 · Mar 31, 2025 $5.25M
Current Liabilities Q1 2025 · Dec 31, 2024 $6.11M
Total Liabilities Q1 2025 · Mar 31, 2025 $5.87M
Total Liabilities Q1 2025 · Dec 31, 2024 $6.13M
Current Assets Q1 2025 · Mar 31, 2025 $5.96M
Current Assets Q1 2025 · Dec 31, 2024 $6.24M
Total Assets Q1 2025 · Mar 31, 2025 $7.76M
Total Assets Q1 2025 · Dec 31, 2024 $7.93M
Shares Diluted Q1 2025 · Mar 31, 2024 163.08M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$518K
Stockholders Equity Q1 2025 · Mar 31, 2024 $2.36M
Stockholders Equity Q1 2025 · Dec 31, 2023 $2.9M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Sga Expense Q1 2025 · Mar 31, 2024 $2.44M
Rd Expense Q1 2025 · Mar 31, 2024 $36K
Net Income Q1 2025 · Mar 31, 2024 −$628K
Operating Income Q1 2025 · Mar 31, 2024 −$620K
Gross Profit Q1 2025 · Mar 31, 2024 $1.85M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $2.15M
Revenue Q1 2025 · Mar 31, 2024 $4M